Is chemotherapy rechallenge feasible in advanced-stage non-small-cell lung cancer?
Sign Up to like & getrecommendations! Published in 2019 at "Bulletin du cancer"
DOI: 10.1016/j.bulcan.2019.04.010
Abstract: BACKGROUND Despite recent progress, non-small cell lung cancer (NSCLC) first-line treatment remains a platinum-based doublet in most cases. No guidelines exist beyond third line. Chemotherapy rechallenge is an option, but little data is available in… read more here.
Keywords: line; treatment; chemotherapy rechallenge; rechallenge ... See more keywords
Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "AntiCancer Research"
DOI: 10.21873/anticanres.15393
Abstract: Background: This study aimed to investigate the response to platinum-based chemotherapy rechallenge in patients with pembrolizumab-refractory urothelial carcinoma. Patients and Methods: We retrospectively reviewed 14 patients with pembrolizumab-refractory urothelial carcinoma. Each patient received a regimen… read more here.
Keywords: platinum based; chemotherapy rechallenge; based chemotherapy; rechallenge ... See more keywords